Navigation Links
CardioMEMS CFO, Dan Bauer, Wins the Delaney Consulting 2011 Excellence in Finance and Accounting Award
Date:11/28/2011

ATLANTA, Nov. 28, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that Chief Financial Officer, Dan Bauer, has won Delaney Consulting, LLC's 2011 Excellence in Financing and Accounting Award in the fast-growth category. The Delaney awards acknowledge accounting and finance professionals from the Metro Atlanta area who exemplify ethics and excellence in their profession and demonstrate exceptional skill, teamwork, and the advancement and application of technical accounting and financial knowledge.

The award ceremony was held at the City Club of Buckhead on November 16, 2011. Five awards were presented, representing emerging growth, fast growth (under $500 million) and large (over $500 million) businesses. A diversity award and a CFOradio Listener's Choice award were also presented. A panel of professionals representing the finance, accounting, and education fields judged the awards.                  

Mr. Bauer began his career at Price Waterhouse and previously served as the Chief Financial Officer for Industriaplex, Granite City Food and Brewery, and Church's Chicken, the largest division of AFC Enterprises.  He is currently a board member for the Association for Corporate Growth, a member of the advisory board of Emerge Scholarships, and an alumnus of Leadership Atlanta.

More information on the Delaney Consulting, LLC Excellence in Financing and Accounting Awards can be found at http://www.delaneyawards.com.

About Delaney Consulting, LLC

Delaney Consulting, LLC is a financial services and executive search firm that provides financial expertise to help companies achieve their financial goals. Clients engage Delaney CFOs and Controllers for their specialized financial experience and skill, whether needed on an interim, part-time or per-project basis. Clients also use Delaney's retained placement services to fit the unique needs of companies during any stage of their business lifecycle – whether the company is growing, optimizing stability or undergoing challenges.

About CardioMEMS, Inc.

CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc.


'/>"/>
SOURCE CardioMEMS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Association of Telecom Professionals Selects Dr. Jay Yadav, CardioMEMS Founder & CEO, as an Atlanta Telecom Professional of the Year in the Industry Innovation Category
2. Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®
3. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
4. CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle
5. CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist
6. CardioMEMS Founder Dr. Jay Yadav Chosen as Health-Care Heroes Finalist by Atlanta Business Chronicle
7. CardioMEMS, Inc. Tops Georgias 2010 Venture Financing List
8. CardioMEMS, Inc. Named a TAG Top 10 Innovative Technology Company
9. CardioMEMS Recognized by Georgia Bio for Pivotal Strategic Partnership
10. Boston Millennia Partners Portfolio Company CardioMEMS Signs Equity Investment and Exclusive Option to be Acquired for an Additional $375,000,000
11. CardioMEMS Completes CHAMPION Clinical Trial Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... In the first ever attempt to include ... from C. sativa, the Hebrew University in Jerusalem, the ... II , the Universita` del Piemonte Orientale and Phytoplant ... and unified inventory of phytocannabinoids of different botanical origin. ... remarkable chemical and structural diversity of phytocannabinoids. As a ...
(Date:12/2/2016)... bioLytical Laboratories, ein Weltführer bei schnellen Tests für Infektionskrankheiten, hat sein ... eingeführt. Continue Reading ... ... , ... ) bioLytical wurde durch die Clinton Health Access ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will ... Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in the ... beyond the standard of care, demonstrating leadership within the MPN community and/or a commitment ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... 2016 , ... The annual time frame to change Medicare health and prescription ... December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan ... to make changes during this period order for their new policy to go into ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain ... an injury, patients must find the one that works for them. When an inventor ... a machine that worked and decided to share it with others. , He developed ...
Breaking Medicine News(10 mins):